The Food and Drug Administration yesterday revised its April 3 emergency use authorization for N95 and similar respirators made in China to remove certain respirators that failed to demonstrate at least 95% particulate filtration efficiency when tested by the National Institute for Occupational Safety and Health. Health care personnel should not use these respirators as personal protective equipment but may use them as face masks, FDA said. The unauthorized models are made by: CTT Co. Ltd; Daddybaby Co. Ltd; Dongguan Xianda Medical Equipment Co. Ltd.; Guangdong Fei Fan Mstar Technology LTD; Guangdong Nuokang Medical Technology Co. Ltd.; Huizhou Huinuo Technology Co. Ltd.; and Lanshan Shendun Technology Co.

Headline
Centers for Medicare & Medicaid Services Administrator Mehmet Oz, M.D., and CMS Deputy Administrator and Director of Medicaid and CHIP Dan Brillman sat…
Headline
Flu and COVID-19 vaccination rates among all health care workers for the 2024-25 respiratory virus season was 76.3% and 40.2%, respectively, according to a…
Headline
A study published March 18 by Science Advances estimated that more than 155,000 U.S. COVID-19 deaths were uncounted during the COVID-19 pandemic. Researchers…
Headline
The Centers for Disease Control and Prevention Feb. 19 released a report on the low use of COVID-19 antiviral drugs among individuals age 65 and older, a…
Headline
The Centers for Medicare & Medicaid Services Jan. 26 released an advanced notice of proposed rulemaking seeking comments on potential future policies to…
Headline
The Food and Drug Administration today released two guidance documents; one related to low-risk wellness products (including certain wearable devices) and the…